1-6 of 6
Sabine Huenecke, PhD.
Close
Sort by
Journal Articles

Phase I/II Study of the Deacetylase Inhibitor Panobinostat As Maintenance Therapy after an Allogeneic Stem Cell Transplantation in Patients with High-Risk MDS or AML: The Panobest-Trial

Gesine Bug, MD, Andreas Burchert, MD, Eva-Maria Wagner, MD, Nicolaus Kroeger, MD, Zuzana Jedlickova, MD, Saskia Gueller, MD, Stephan Metzelder, MD, Andrea Wolf, Peter Bader, MD, Sabine Huenecke, PhD, Hubert Serve, Oliver G. Ottmann, MD
Journal: Blood
Blood (2015) 126 (23): 4344.
https://doi.org/10.1182/blood.V126.23.4344.4344
Published: 2015
Journal Articles

Repetitive Infusions of Cytokine-Induced Killer (CIK) Cells for Treatment of Impending Relapse in High-Risk Leukemia Patients after Allogeneic Stem Cell Transplantation

Eva Rettinger, MD, Sabine Huenecke, PhD, Verena Pfirrmann, Michael Merker, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Halvard Boenig, Prof., Gesine Bug, MD, Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 2438.
https://doi.org/10.1182/blood.V124.21.2438.2438
Published: 2014
Journal Articles

CMV-Specific Cytokine-Induced Killer Cells Comprise Concomitant Cytotoxicity Against Leukemia and Cytomegalovirus

Verena Pfirrmann, Sarah Oelsner, Eva Rettinger, MD, Sabine Huenecke, PhD, Jindrich Cinatl, Prof., Winfried Wels, Prof., Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 5814.
https://doi.org/10.1182/blood.V124.21.5814.5814
Published: 2014
Journal Articles

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Eva Rettinger, MD, Michael Merker, MD, Hermann Kreyenberg, PhD, Thomas Krenn, MD, Matthias Dürken, MD, Jörg Faber, MD PhD, Sabine Huenecke, PhD, Claudia Brehm, PhD, Melanie Bremm, PhD, Shahrzad Bakhtiar, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Thomas Klingebiel, Prof., Peter Bader
Journal: Blood
Blood (2014) 124 (21): 3953.
https://doi.org/10.1182/blood.V124.21.3953.3953
Published: 2014
Journal Articles

Post-Transplant Maintenance With The Deacetylase Inhibitor Panobinostat In Patients With High-Risk AML Or MDS: Results Of The Phase I Part Of The Panobest Trial

Gesine Bug, MD, PhD, Andreas Burchert, MD, Kroeger Nicolaus, MD, Sabine Huenecke, PhD, Ulrich Duenzinger, MD, Andrea Wolf, Peter Bader, Hubert Serve, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2013) 122 (21): 3315.
https://doi.org/10.1182/blood.V122.21.3315.3315
Published: 2013
Journal Articles

Phenotypic and Functional Characterization of Mesenchymal Stromal Cells Derived from CD271 + - Bone Marrow Mononuclear Cells and Mesenchymal Stromal Cells Derived through Plastic Adherence.

Selim Kuci, MD, PhD, Kathrin Puetsch, TA, Zyrafete Kuci, MD., Sabine Huenecke, PhD., Hermann Kreyenberg, PhD., Chandra Sekhar Amara, M.Sci., Christoph Piechaczek, PhD., Ulrike Koehl, MD., PhD., Thomas Klingebiel, MD., Peter Bader, MD.
Journal: Blood
Blood (2007) 110 (11): 1921.
https://doi.org/10.1182/blood.V110.11.1921.1921
Published: 2007